Trademark: 90346293
Word
HITKIT
Status Date
Monday, September 2, 2024
Filing Date
Saturday, November 28, 2020
Published for Opposition
Tuesday, December 7, 2021
Abandoned Date
Monday, September 2, 2024
5 Pharmaceuticals, namely, a partial agonist of N-methyl-D-aspartame (NMDA) receptors at low dose and a partial antagonist of NMDA at high dose, an inhibitor of microglial activation, and a modulator of NMDA receptors; antibiotics; pharmaceuticals and antibiotics for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; pharmaceuticals and antibiotics for reversing the damage caused by concussion or traumatic brain injury
35 Retail store services featuring drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury
44 Medical services, namely, providing medical services using drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury
10 Drug delivery system, namely, an intramuscular autoinjector and an intramuscular drug delivery autoinjector; drug delivery system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury, namely, an intramuscular autoinjector, and an intramuscular needle-based injection system; an intramuscular needle-based injection system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; drug delivery system for reversing the damage caused by concussion or traumatic brain injury, namely, intramuscular autoinjector and an intramuscular needle-based injection system
Dec 2, 2020
New Application Entered
Dec 7, 2020
Teas Voluntary Amendment Received
Dec 7, 2020
Teas Amendment Entered Before Attorney Assigned
May 20, 2021
Non-Final Action E-Mailed
Feb 3, 2021
New Application Office Supplied Data Entered
May 13, 2021
Assigned To Examiner
May 20, 2021
Non-Final Action Written
May 20, 2021
Notification Of Non-Final Action E-Mailed
Nov 1, 2021
Approved For Pub - Principal Register
Oct 12, 2021
Examiners Amendment -Written
Oct 12, 2021
Examiners Amendment E-Mailed
Oct 12, 2021
Notification Of Examiners Amendment E-Mailed
Oct 12, 2021
Examiner's Amendment Entered
Oct 12, 2021
Examiners Amendment -Written
Oct 12, 2021
Examiners Amendment E-Mailed
Oct 12, 2021
Notification Of Examiners Amendment E-Mailed
Oct 12, 2021
Examiner's Amendment Entered
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 14, 2022
Sou Teas Extension Received
Dec 7, 2021
Published For Opposition
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2022
Sou Extension 1 Filed
Jul 14, 2022
Sou Extension 1 Granted
Jul 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2023
Sou Teas Extension Received
Jan 26, 2023
Sou Extension 2 Filed
Jan 26, 2023
Sou Extension 2 Granted
Jan 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2023
Sou Extension 3 Filed
Jul 26, 2023
Sou Extension 3 Granted
Jan 30, 2024
Sou Teas Extension Received
Jul 26, 2023
Sou Teas Extension Received
Jul 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2024
Sou Extension 4 Filed
Jan 30, 2024
Sou Extension 4 Granted
Jul 11, 2024
Automatic Update Of Assignment Of Ownership
Sep 2, 2024
Abandonment - No Use Statement Filed
Sep 2, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
